Pharming Group N.V./€PHARM

05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX

About Pharming Group N.V.

Pharming Group N.V. is a biotechnology company specializing in the development, production, and commercialization of human therapeutic proteins to treat rare diseases. Its core product, Ruconest, is a recombinant human C1 esterase inhibitor used for the treatment of angioedema attacks in patients with hereditary angioedema. Founded in 1988, the company operates primarily from its headquarters in Leiden, Netherlands. Pharming employs proprietary protein-expression technology in the production of these therapeutic proteins, which enables efficient and scalable production processes. The company’s strategic focus on rare diseases and its unique technology platform position it to address unmet medical needs, providing a competitive edge in the biopharmaceutical market.

Ticker

€PHARM

Primary listing

AEX

Industry

Biotechnology

Employees

404

ISIN

NL0010391025

PHARM Metrics

BasicAdvanced
€606M
-
-€0.02
0.44
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €PHARM

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs